276 related articles for article (PubMed ID: 12586614)
1. Performance- and safety-enhanced lentiviral vectors containing the human interferon-beta scaffold attachment region and the chicken beta-globin insulator.
Ramezani A; Hawley TS; Hawley RG
Blood; 2003 Jun; 101(12):4717-24. PubMed ID: 12586614
[TBL] [Abstract][Full Text] [Related]
2. The β-interferon scaffold attachment region confers high-level transgene expression and avoids extinction by epigenetic modifications of integrated provirus in adipose tissue-derived human mesenchymal stem cells.
Moreno R; Martínez I; Petriz J; Nadal M; Tintoré X; Gonzalez JR; Gratacós E; Aran JM
Tissue Eng Part C Methods; 2011 Mar; 17(3):275-87. PubMed ID: 20846052
[TBL] [Abstract][Full Text] [Related]
3. Successful correction of the human Cooley's anemia beta-thalassemia major phenotype using a lentiviral vector flanked by the chicken hypersensitive site 4 chromatin insulator.
Malik P; Arumugam PI; Yee JK; Puthenveetil G
Ann N Y Acad Sci; 2005; 1054():238-49. PubMed ID: 16339671
[TBL] [Abstract][Full Text] [Related]
4. Lentiviral vectors for enhanced gene expression in human hematopoietic cells.
Ramezani A; Hawley TS; Hawley RG
Mol Ther; 2000 Nov; 2(5):458-69. PubMed ID: 11082319
[TBL] [Abstract][Full Text] [Related]
5. Combinatorial incorporation of enhancer-blocking components of the chicken beta-globin 5'HS4 and human T-cell receptor alpha/delta BEAD-1 insulators in self-inactivating retroviral vectors reduces their genotoxic potential.
Ramezani A; Hawley TS; Hawley RG
Stem Cells; 2008 Dec; 26(12):3257-66. PubMed ID: 18787211
[TBL] [Abstract][Full Text] [Related]
6. Targeting transgene expression to antigen-presenting cells derived from lentivirus-transduced engrafting human hematopoietic stem/progenitor cells.
Cui Y; Golob J; Kelleher E; Ye Z; Pardoll D; Cheng L
Blood; 2002 Jan; 99(2):399-408. PubMed ID: 11781219
[TBL] [Abstract][Full Text] [Related]
7. Boundary sequences stabilize transgene expression from subtle position effects in retroviral vectors.
Moreno R; Martinez I; Petriz J; González JR; Gratacós E; Aran JM
Blood Cells Mol Dis; 2009; 43(2):214-20. PubMed ID: 19632138
[TBL] [Abstract][Full Text] [Related]
8. Expression of a human beta-globin transgene in erythroid cells derived from retrovirally transduced transplantable human fetal liver and cord blood cells.
Nicolini FE; Imren S; Oh IH; Humphries RK; Leboulch P; Fabry ME; Nagel RL; Eaves CJ
Blood; 2002 Aug; 100(4):1257-64. PubMed ID: 12149206
[TBL] [Abstract][Full Text] [Related]
9. Chicken HS4 insulators have minimal barrier function among progeny of human hematopoietic cells transduced with an HIV1-based lentiviral vector.
Uchida N; Washington KN; Lap CJ; Hsieh MM; Tisdale JF
Mol Ther; 2011 Jan; 19(1):133-9. PubMed ID: 20940706
[TBL] [Abstract][Full Text] [Related]
10. Lentiviral vectors with two independent internal promoters transfer high-level expression of multiple transgenes to human hematopoietic stem-progenitor cells.
Yu X; Zhan X; D'Costa J; Tanavde VM; Ye Z; Peng T; Malehorn MT; Yang X; Civin CI; Cheng L
Mol Ther; 2003 Jun; 7(6):827-38. PubMed ID: 12788657
[TBL] [Abstract][Full Text] [Related]
11. A chimeric HS4-SAR insulator (IS2) that prevents silencing and enhances expression of lentiviral vectors in pluripotent stem cells.
Benabdellah K; Gutierrez-Guerrero A; Cobo M; Muñoz P; Martín F
PLoS One; 2014; 9(1):e84268. PubMed ID: 24400083
[TBL] [Abstract][Full Text] [Related]
12. High-level erythroid lineage-directed gene expression using globin gene regulatory elements after lentiviral vector-mediated gene transfer into primitive human and murine hematopoietic cells.
Hanawa H; Persons DA; Nienhuis AW
Hum Gene Ther; 2002 Nov; 13(17):2007-16. PubMed ID: 12489996
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional targeting of lentiviral vectors by long terminal repeat enhancer replacement.
Lotti F; Menguzzato E; Rossi C; Naldini L; Ailles L; Mavilio F; Ferrari G
J Virol; 2002 Apr; 76(8):3996-4007. PubMed ID: 11907239
[TBL] [Abstract][Full Text] [Related]
14. High-level erythroid-specific gene expression in primary human and murine hematopoietic cells with self-inactivating lentiviral vectors.
Moreau-Gaudry F; Xia P; Jiang G; Perelman NP; Bauer G; Ellis J; Surinya KH; Mavilio F; Shen CK; Malik P
Blood; 2001 Nov; 98(9):2664-72. PubMed ID: 11675336
[TBL] [Abstract][Full Text] [Related]
15. Extended core sequences from the cHS4 insulator are necessary for protecting retroviral vectors from silencing position effects.
Aker M; Tubb J; Groth AC; Bukovsky AA; Bell AC; Felsenfeld G; Kiem HP; Stamatoyannopoulos G; Emery DW
Hum Gene Ther; 2007 Apr; 18(4):333-43. PubMed ID: 17411365
[TBL] [Abstract][Full Text] [Related]
16. High-level sustained transgene expression in human embryonic stem cells using lentiviral vectors.
Ma Y; Ramezani A; Lewis R; Hawley RG; Thomson JA
Stem Cells; 2003; 21(1):111-7. PubMed ID: 12529558
[TBL] [Abstract][Full Text] [Related]
17. Critical factors influencing stable transduction of human CD34(+) cells with HIV-1-derived lentiviral vectors.
Haas DL; Case SS; Crooks GM; Kohn DB
Mol Ther; 2000 Jul; 2(1):71-80. PubMed ID: 10899830
[TBL] [Abstract][Full Text] [Related]
18. Effect of scaffold attachment region on transgene expression in retrovirus vector-transduced primary T cells and macrophages.
Auten J; Agarwal M; Chen J; Sutton R; Plavec I
Hum Gene Ther; 1999 May; 10(8):1389-99. PubMed ID: 10365668
[TBL] [Abstract][Full Text] [Related]
19. Hybrid HIV/MSCV LTR enhances transgene expression of lentiviral vectors in human CD34(+) hematopoietic cells.
Choi JK; Hoang N; Vilardi AM; Conrad P; Emerson SG; Gewirtz AM
Stem Cells; 2001; 19(3):236-46. PubMed ID: 11359949
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of molecular strategies attenuating positional effects in lentiviral vectors carrying multiple genes.
Osti D; Marras E; Ceriani I; Grassini G; Rubino T; Viganò D; Parolaro D; Perletti G
J Virol Methods; 2006 Sep; 136(1-2):93-101. PubMed ID: 16690138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
